Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

ENVB
Enveric Biosciences, Inc. Common Stock
stock NASDAQ

At Close
May 16, 2025 3:59:30 PM EDT
1.32USD+4.762%(+0.06)2,847,262
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 16, 2025 8:45:30 AM EDT
1.22USD-2.921%(-0.04)1,200
After-hours
May 16, 2025 4:58:30 PM EDT
1.61USD+21.970%(+0.29)2,055,266
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 27, 2022
07:30AM EST  Enveric Biosciences to Participate in Upcoming Investor Conferences in February   PR Newswire
Jan 18, 2022
07:30AM EST  Enveric Biosciences CEO, Dr. Joseph Tucker, Provides 2021 Year in Review and   PR Newswire
Jan 6, 2022
04:01PM EST  Enveric Biosciences to Participate in the H.C. Wainwright BioConnect Conference   PR Newswire
Dec 30, 2021
09:37AM EST  2021 Was The Year Psychedelics Conquered Capitalism...Or Is It The Other Way Around?   Benzinga
Dec 10, 2021
12:25PM EST  Cannabis Movers & Shakers: NORML, TGOD, Enveric Biosciences, Dalwhinnie Enterprises   Benzinga
Dec 6, 2021
08:00AM EST  Biotechnology company Enveric Biosciences (ENVB) announced Monday the appointment of Bob Dagher, MD, as Chief Medical Officer, effective immediately. Dagher succeeds Robert Wilkins, MD, who stepped down on November 29, 2021 after serving in the role for two years.   RTTNews
07:32AM EST  Enveric Biosciences Appoints Bob Dagher As Chief Medical Officer   RTTNews
07:31AM EST  Enveric Biosciences Appoints Dr. Bob Dagher as Chief Medical Officer   PR Newswire
Nov 29, 2021
07:30AM EST  Enveric Biosciences to Participate in the H.C. Wainwright 2nd Annual   PR Newswire
Nov 18, 2021
10:54AM EST  Enveric Biosciences' CBD-Based Product Reduces Dermatitis Severity In Animal Study   Benzinga
07:38AM EST  Enveric Biosciences Reports Preclinical Data For EV102 Radiodermatitis Drug Candidate: Showed Reduction In Severity Of Dermatitis   Benzinga
07:30AM EST  Enveric Biosciences Announces Positive Preclinical Data for EV102   PR Newswire
Nov 16, 2021
04:06AM EST  Earnings Scheduled For November 16, 2021   Benzinga
Nov 10, 2021
06:06AM EST  The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 05.30 A.M. ET).   RTTNews
Nov 8, 2021
07:30AM EST  Enveric Biosciences Announces Inclusion in AdvisorShares Psychedelics ETF   PR Newswire
Oct 26, 2021
07:47AM EDT  Enveric Biosciences To Participate In Wonderland: Miami Conference Nov. 8-9   Benzinga
07:31AM EDT  Enveric Biosciences to Participate in Wonderland: Miami Conference   PR Newswire
Oct 18, 2021
01:37PM EDT  Psyched: The 50 Publicly-listed Psychedelics Companies, Atai's New Subsidiary, PharmaTher Gets New Orphan Drug Designation   Benzinga
08:36AM EDT  KCSA Psychedelics Virtual Investor Conference Presentations Available for   PR Newswire
Oct 13, 2021
04:25PM EDT  There Are Now 50 Psychedelics Companies Listed In The U.S. - Here They Are   Benzinga
Oct 7, 2021
07:31AM EDT  Enveric Biosciences to Participate in Upcoming Investor Conferences in October   PR Newswire
Oct 5, 2021
09:08AM EDT  Bringing Mental Health Pharmacology into the 21st Century: How the Marriage of Enveric Biosciences and MagicMed Industries Could Revolutionize the Way We Treat Mental Health   Benzinga
07:39AM EDT  Enveric Biosciences : PsyAI Identifies Viable Drug Candidates From 'Psybrary' Of Psychedelic Molecular Compounds   RTTNews
07:37AM EDT  Enveric Biosciences Announces PsyAI Has Discovered Viable Psychedelic Molecules For Further Drug Discovery   Benzinga
07:31AM EDT  Identified Viable Drug Candidates from its 'Psybrary' of Psychedelic Molecular Compounds   PR Newswire
Sep 30, 2021
03:40PM EDT  From BZ's Small Cap Healthcare Conference: Enveric Biosciences Director & CEO, Dr. Joseph Tucker Begins Speaking   Benzinga
03:16PM EDT  4 Stocks Disrupting Mental Health To Keep An Eye On At Benzinga's Healthcare Conference   Benzinga
Sep 20, 2021
12:51PM EDT  Psyched: First Active Psychedelics ETF Hits NYSE, Compass Dives Into Novel Molecules, Atai Subsidiary Launches Phase 2a Trial   Benzinga
07:01AM EDT  Enveric Biosciences to Participate in Upcoming Investor Conferences in   PR Newswire
Sep 17, 2021
02:53PM EDT  Nasdaq Welcomes New Psychedelics Company In $23M M&A Transaction   Benzinga
08:04AM EDT  Enveric Biosciences (ENVB), a biotechnology company developing cannabinoid medicines, on Friday announced the closing of its acquisition of privately held MagicMed Industries Inc.   RTTNews
07:10AM EDT  Enveric Biosciences Announces Closing Of MagicMed Industries Acquisition   RTTNews
Sep 14, 2021
12:54PM EDT  Meet The Top 12 CEOs In The Psychedelics Industry   Benzinga
Sep 9, 2021
04:46PM EDT  Psychedelic Medicine's Top CEOs: Who's Running The Biggest Companies In This Booming Industry?   Benzinga
07:31AM EDT  Enveric Biosciences Announces MagicMed Industries' Presentations at the   PR Newswire
Aug 18, 2021
09:15AM EDT  Enveric Biosciences CEO, David Johnson, Earlier Issued Letter To Shareholders   Benzinga
08:01AM EDT  Enveric Biosciences CEO, David Johnson, Issues Letter to Shareholders   PR Newswire
07:38AM EDT  The Daily Biotech Pulse: AzurRx Jumps On Data, Agios' Regulatory Application For Mitapivat Accepted For Priority Review, FDA Nod For GlaxoSmithKline   Benzinga
Aug 17, 2021
08:28AM EDT  The Daily Biotech Pulse: Lilly Reorganizes Business Units In Neuroscience Focus, Helius Medical Spikes On Breakthrough Designation, Ra Medical Sells Dermatology Business   Benzinga
Jul 23, 2021
06:10PM EDT  Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To 'Psychedelics Renaissance'   Benzinga
05:04PM EDT  Field Trip Health Heads To The Nasdaq As Wall Street Opens Up To "Psychedelics Renaissance"   Benzinga
Jul 20, 2021
08:20AM EDT  The Daily Biotech Pulse: Ardelyx Sinks On Regulatory Setback, AnPac Issues Positive Preannouncement, European Nod For Myovant, HCW Biologics Debuts On Wall Street   Benzinga
Jul 9, 2021
10:31AM EDT  Watch CV Sciences & Lyphe Group On The Benzinga Cannabis Hour   Benzinga
Jul 8, 2021
10:03AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For July 8, 2021   Benzinga
09:32AM EDT  Aegis Capital Initiates Coverage On Enveric Biosciences with Buy Rating, Announces Price Target of $7   Benzinga
08:10AM EDT  Enveric Biosciences : Israel Approves To Begin Phase 1/2 Trial Of Triple-Combination CBD Treatment For Glioblastoma   RTTNews
08:02AM EDT  Begin its Phase 1/2 Trial of Triple-Combination CBD Treatment for Glioblastoma   PR Newswire
08:01AM EDT  Enveric Biosciences Reports Approval From Israel's Ministry Of Health To Begin Phase 1/2 Trial Of Triple-Combo CBD Treatment For Glioblastoma   Benzinga
Jul 3, 2021
12:32PM EDT  Psyched: GH Research Debuts on Nasdaq, Compass Reaches Psilocybin Research Milestone, Maxim Gives BUY Rating to 10 Psychedelics Companies   Benzinga
Jun 30, 2021
06:14PM EDT  Maxim Group Gives Buy Rating To 10 Psychedelic Stocks: Compass, MindMed, Cybin, Field Trip And More   Benzinga
Jun 28, 2021
10:21AM EDT  Benzinga's Top Ratings Upgrades, Downgrades For June 28, 2021   Benzinga
09:00AM EDT  Maxim Group Initiates Coverage On Enveric Biosciences with Buy Rating, Announces Price Target of $6   Benzinga
Jun 23, 2021
10:49AM EDT  Privately Owned MagicMed Industries Inc. is Psyched to Join Forces with Public Pharma Co. Enveric   Benzinga
Jun 7, 2021
07:00AM EDT  EmergingGrowth.com a leading independent small cap media portal with an extensive history of providing unparalleled content for the Emerging Growth Companies and Markets announces the Schedule of the 9th Emerging Growth Conference.   GlobeNewswire Inc
Jun 4, 2021
04:50PM EDT  EXCLUSIVE: MagicMed CEO On Psychedelics Company's 'Secret Sauce,' M&A Deal With Enveric Biosciences   Benzinga
Jun 3, 2021
09:01AM EDT  Enveric Biosciences and MagicMed to Participate in June 2021 Investor and   PR Newswire
Jun 1, 2021
06:57PM EDT  ENVERIC BIOSCIENCES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Enveric Biosciences, Inc. - ENVB   Business Wire
May 28, 2021
03:45PM EDT  Psyched: Nasdaq Gets Its Third Psychedelics Company, Mynd Goes Public, Delic Buys New Research Facility   Benzinga
May 24, 2021
12:58PM EDT  Another Psychedelics Company Joins 'Exclusive Nasdaq Group' With Enveric's Acquisition Of MagicMed Industries   Benzinga
06:37AM EDT  Enveric Biosciences (ENVB) , a patient-first biotechnology company developing novel cannabinoid medicines, announced Monday that it has entered into a definitive agreement to acquire MagicMed Industries Inc., a pharmaceutical drug discovery and development platform, in an all-stock transaction.   RTTNews
06:03AM EDT  Enveric Biosciences to Acquire MagicMed Industries; No Terms Disclosed   Benzinga
06:02AM EDT  Enveric Biosciences Agrees To Acquire MagicMed Industries   RTTNews
06:01AM EDT  Industries, a Pharmaceutical Drug Discovery and Development Platform Focused on New-Generation Psychedelic Molecular Compounds and Derivatives   PR Newswire
May 21, 2021
10:18AM EDT  Enveric Biosciences, Inc. (ENVB) shares are trading more than 16 percent on Friday morning, continuing a positive trend since May 14. There was no corporate announcement today to influence stock movement.   RTTNews
May 18, 2021
07:37AM EDT  Enveric Biosciences Q1 Loss/Shr 0.20 Vs Loss/Shr $0.19 Last Year   RTTNews
07:36AM EDT  Enveric Biosciences Q1 EPS $(0.20) Down From $(0.02) YoY   Benzinga
07:31AM EDT  Enveric Biosciences Reports First Quarter 2021 Financial Results   PR Newswire
May 14, 2021
07:59AM EDT  The Daily Biotech Pulse: CorMedix Slumps On Delay In Resubmission of DefenCath NDA, Apellis Awaits FDA Decision, Vera Therapeutics Debuts   Benzinga
May 12, 2021
08:57AM EDT  The Daily Biotech Pulse: Minerva, InflaRx Report Positive Data Readouts, Lucira COVID-19 Test Kit Available On Amazon, Decision Day For Heron   Benzinga
07:33AM EDT  Enveric Biosciences Appoints Arash Asher To Scientific Advisory Board   RTTNews
07:30AM EDT  Enveric Biosciences Appoints Dr. Arash Asher to Scientific Advisory Board   PR Newswire
May 11, 2021
07:54AM EDT  The Daily Biotech Pulse: FDA Authorizes Pfizer-BioNTech COVID-19 Vaccine For Adolescents, Lilly Strikes R&D Collaboration, Vaccine Stocks Novavax, Inovio Sink On Earnings   Benzinga
Apr 22, 2021
08:09AM EDT  The Daily Biotech Pulse: KemPharm Receives $10M Milestone Payment, Zymergen, Neuropace Debut On Nasdaq, Renalytix Wins US Government Contract, 2 IPOs   Benzinga
Apr 21, 2021
07:31AM EDT  The Daily Biotech Pulse: Moderna To Supply Variant-Specific Vaccine To Israel, Roche's Diagnostics Business Comes to Rescue   Benzinga
Apr 16, 2021
08:01AM EDT  The Daily Biotech Pulse: Precision Biosciences Regains Rights To CAR T Candidates, CFO Changes, 2 IPOs   Benzinga
Apr 12, 2021
07:43AM EDT  Enveric Biosciences (ENVB) has appointed Carter Ward as CFO, effective May 15th, 2021. He is replacing John Van Buiten. Prior to joining the company, Ward most recently served as CFO at Elite Pharmaceuticals. John Van Buiten is expected to remain in a consulting role with the company.   RTTNews
07:37AM EDT  Enveric Biosciences Appoints Carter Ward As Chief Financial Officer   Benzinga
07:34AM EDT  Enveric Biosciences Appoints Carter Ward As CFO, Effective May 15   RTTNews
07:31AM EDT  Enveric Biosciences Appoints Carter Ward as Chief Financial Officer   PR Newswire
Apr 1, 2021
08:03AM EDT  Enveric Biosciences Reports Full Year 2020 Financial Results and Provides   PR Newswire
08:02AM EDT  Enveric Biosciences FY20 Net Cash Used In Operating Activities $3.889M, Opex $5.6M   Benzinga
Mar 26, 2021
04:39PM EDT  Highlights From Day 2 Of Benzinga's Biotech Small Cap Conference   Benzinga
Mar 18, 2021
08:02AM EDT  Enveric Biosciences Appoints Dr. Douglas D. Lind to Company's Board of Directors   PR Newswire
Mar 16, 2021
08:32AM EDT  Diverse Biotech Announces Strategic Transaction With Enveric Biosciences To License Exclusive Worldwide Development, Commercialization Rights For 5 Novel Compounds   Benzinga
08:22AM EDT  Diverse Biotech announces Strategic Transaction with Enveric Biosciences   PR Newswire
Mar 15, 2021
08:01AM EDT  Enveric Biosciences to Participate in Upcoming Investor Conferences in March   PR Newswire
Mar 11, 2021
12:59PM EST  Mid-Day Market Update: Crude Oil Rises Over 2%; Siebert Financial Shares Spike Higher   Benzinga
10:22AM EST  Mid-Morning Market Update: Markets Open Higher; US Initial Jobless Claims Drop To 712,000   Benzinga
Mar 10, 2021
02:37PM EST  Mid-Afternoon Market Update: Dow Surges 500 Points; US Budget Deficit Widens In February   Benzinga
12:53PM EST  Mid-Day Market Update: Dow Jumps Over 400 Points; Just Energy Shares Slide   Benzinga
10:12AM EST  Mid-Morning Market Update: Markets Open Higher; Campbell Soup Reports In-Line Earnings   Benzinga
09:24AM EST  Enveric Biosciences Stock Skyrockets After Licensing Agreement With Diverse Biotech   Benzinga
08:25AM EST  Benzinga Pro's Top 5 Stocks To Watch For Wednesday, Mar. 10, 2021: RBLX, LPSN, ENVB, XSPA, SINT   Benzinga
08:09AM EST  Enveric Biosciences Reports Deal To Buy Exclusive License For Novel Molecules From Diverse Biotech, No Terms Disclosed   Benzinga
08:06AM EST  Enveric Biosciences Signs Agreement To Acquire Exclusive License For Novel Molecules From Diverse Biotech   RTTNews
08:01AM EST  Enveric Biosciences Signs Definitive Agreement to Acquire Exclusive License for   PR Newswire
Feb 25, 2021
07:49AM EST  Enveric Biosciences Launches Development Collaboration and Supply Agreement with PureForm Global to Support Cannabinoid Clinical Programs   Benzinga
07:03AM EST  Enveric Biosciences Launches Development Collaboration and Supply Agreement   PR Newswire
Feb 12, 2021
08:31AM EST  Enveric Biosciences Inc. Announces Closing of $12.8 Million Registered Direct   PR Newswire
Feb 10, 2021
06:42AM EST  Bezalel Partners, LLC Discloses 9.99% Passive Stake In Enveric Biosciences   Benzinga
Feb 9, 2021
09:31AM EST  Enveric Biosciences Plans $12.8 Mln Registered Direct Offering   RTTNews
09:28AM EST  Enveric Biosciences Announces $12.8M Offering Of ~3M Shares At $4.27/Share   Benzinga
09:28AM EST  Enveric Biosciences Inc. Announces $12.8 Million Registered Direct Offering   PR Newswire
Jan 21, 2021
10:35AM EST  Biosciences, Inc. for Potential Breaches of Fiduciary Duty By Its Board of Directors   PR Newswire
Jan 19, 2021
08:32AM EST  Enveric Biosciences Issues Shareholder Letter Providing Strategic Vision for   PR Newswire
08:31AM EST  Enveric Biosciences Issues Shareholder Letter   Benzinga
Jan 15, 2021
04:01PM EST  Enveric Biosciences Inc. Announces Closing of $10 Million Registered Direct   PR Newswire
Jan 12, 2021
03:58PM EST  Pinches Abowitz Reports In 13G Filing An 8% Stake In Enveric Biosciences   Benzinga
02:31PM EST  Mid-Afternoon Market Update: Dow Rises 50 Points; Qilian International Shares Spike Higher   Benzinga
12:27PM EST  Mid-Day Market Update: VOXX International Jumps Following Q3 Earnings; RedHill Biopharma Shares Slide   Benzinga
09:13AM EST  Enveric Biosciences Announces $10M Registered Direct Offering Of 2.221M Shares At $4.5018/Share   Benzinga
09:04AM EST  Enveric Biosciences Inc. Announces $10 Million Registered Direct Offering   PR Newswire
Jan 5, 2021
08:31AM EST  Enveric Biosciences Appoints Dr. Marcus Schabacker to Board of Directors   PR Newswire


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC